Absci Corp Stock Today
| ABSI Stock | USD 2.69 0.08 3.07% |
PerformanceWeakest
| Odds Of DistressLow
|
Absci Corp is trading at 2.69 as of the 23rd of September 2025. This is a 3.07% increase since the beginning of the trading day. The stock's open price was 2.61. Absci Corp has about a 23 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 25th of June 2025 and ending today, the 23rd of September 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 22nd of July 2021 | Category Healthcare | Classification Health Care |
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington. The company has 149.52 M outstanding shares of which 31.61 M shares are presently shorted by private and institutional investors with about 6.5 trading days to cover. More on Absci Corp
Moving against Absci Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Absci Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Biotechnology, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | ||||
| Average Analyst Recommendation | |||||
Debt LevelsAbsci Corp can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Absci Corp's financial leverage. It provides some insight into what part of Absci Corp's total assets is financed by creditors.
| |||||
Absci Corp (ABSI) is traded on NASDAQ Exchange in USA. It is located in 18105 SE Mill Plain Boulevard, Vancouver, WA, United States, 98683 and employs 156 people. Absci Corp is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 390.25 M. Absci Corp conducts business under Biotechnology sector and is part of Health Care industry. The entity has 149.52 M outstanding shares of which 31.61 M shares are presently shorted by private and institutional investors with about 6.5 trading days to cover.
Absci Corp currently holds about 206.02 M in cash with (72.4 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.22.
Check Absci Corp Probability Of Bankruptcy
Ownership AllocationAbsci Corp holds a total of 149.52 Million outstanding shares. Over half of Absci Corp's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Absci Ownership Details
Absci Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Bank Of America Corp | 2025-06-30 | 1.9 M | |
| State Street Corp | 2025-06-30 | 1.8 M | |
| Royce & Associates, Lp | 2025-06-30 | 1.5 M | |
| Sumitomo Mitsui Trust Group Inc | 2025-06-30 | 1.5 M | |
| Amova Asset Management Americas, Inc | 2025-06-30 | 1.4 M | |
| Morgan Stanley - Brokerage Accounts | 2025-06-30 | 1.2 M | |
| Casdin Capital, Llc | 2025-06-30 | 973.3 K | |
| Dimensional Fund Advisors, Inc. | 2025-06-30 | 839.2 K | |
| Charles Schwab Investment Management Inc | 2025-06-30 | 822.7 K | |
| Fmr Inc | 2025-06-30 | 19.1 M | |
| Ark Investment Management Llc | 2025-06-30 | 10 M |
Absci Corp Historical Income Statement
Absci Stock Against Markets
Absci Corp Corporate Management
| Sean McClain | CEO, Founder | Profile | |
| CPA CPA | Chief Officer | Profile | |
| Christian MBA | Senior Creation | Profile | |
| Shelby JD | Chief Officer | Profile | |
| Karin Wierinck | Chief Officer | Profile | |
| Sarah JD | Chief Sec | Profile | |
| Jens Plassmeier | Senior Technology | Profile |
Already Invested in Absci Corp?
The danger of trading Absci Corp is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Absci Corp is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Absci Corp. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Absci Corp is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Absci Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Absci Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Absci Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Absci Corp Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Absci Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. For more detail on how to invest in Absci Stock please use our How to Invest in Absci Corp guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Absci Corp. If investors know Absci will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Absci Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.95) | Revenue Per Share | Quarterly Revenue Growth (0.53) | Return On Assets | Return On Equity |
The market value of Absci Corp is measured differently than its book value, which is the value of Absci that is recorded on the company's balance sheet. Investors also form their own opinion of Absci Corp's value that differs from its market value or its book value, called intrinsic value, which is Absci Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Absci Corp's market value can be influenced by many factors that don't directly affect Absci Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Absci Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Absci Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Absci Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.